CompletedPhase 2NCT01527682
Efficacy and Safety of Topically Applied Medical Therapy for the Treatment of Pediatric Glaucoma
Studying OBSOLETE: Rare genetic glaucoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
- Principal Investigator
- Luciano Quaranta, MDUniversità di Brescia, Spedali Civili di Brescia
- Intervention
- Latanoprost, Dorzolamide(drug)
- Enrollment
- 37 enrolled
- Eligibility
- 12 years · All sexes
- Timeline
- 2009 – 2016
Study locations (2)
- Azienda Ospedaliera Spedali Civili di Brescia, Brescia, Italy
- A.O. Universitaria " Policlinico Vittorio Emanuele" P.O. Rodolico, Catania, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01527682 on ClinicalTrials.gov